These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26437286)

  • 21. [Trichophyton rubrum onychomycosis with secondary Aspergillus versicolor infection in a 12-year-old girl: successful topical therapy with terbinafine-urea ointment].
    Mayser PA; Gries A; Hamrouni N
    Hautarzt; 2014 Jul; 65(7):628-32. PubMed ID: 24817253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Onychomycosis by Paecilomyces lilacinus.
    Pontini P; Gorani A; Veraldi S
    G Ital Dermatol Venereol; 2016 Dec; 151(6):706-709. PubMed ID: 27824223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luliconazole: a review of a new antifungal agent for the topical treatment of onychomycosis.
    Scher RK; Nakamura N; Tavakkol A
    Mycoses; 2014 Jul; 57(7):389-93. PubMed ID: 24621346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
    Zane LT; Plattner J; Chanda S; Coronado D; Merchant T; Alley MR; Gupta AK
    Drugs Today (Barc); 2015 Oct; 51(10):599-607. PubMed ID: 26583302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access of efinaconazole topical solution, 10%, to the infection site by spreading through the subungual space.
    Elewski BE; Pollak RA; Pillai R; Olin JT
    J Drugs Dermatol; 2014 Nov; 13(11):1394-8. PubMed ID: 25607708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.
    Aly R; Gupta AK; Winter T; Zane LT; Vlahovic T
    J Drugs Dermatol; 2017 Oct; 16(10):1016-1021. PubMed ID: 29036255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
    Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
    Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial.
    Sotiriou E; Koussidou-Eremonti T; Chaidemenos G; Apalla Z; Ioannides D
    Acta Derm Venereol; 2010 Mar; 90(2):216-7. PubMed ID: 20169321
    [No Abstract]   [Full Text] [Related]  

  • 33. Antifungal agents for onychomycosis: new treatment strategies to improve safety.
    Zane LT; Chanda S; Coronado D; Del Rosso J
    Dermatol Online J; 2016 Mar; 22(3):. PubMed ID: 27136621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terbinafine hydrochloride loaded liposome film formulation for treatment of onychomycosis: in vitro and in vivo evaluation.
    Tanrıverdi ST; Hilmioğlu Polat S; Yeşim Metin D; Kandiloğlu G; Özer Ö
    J Liposome Res; 2016; 26(2):163-73. PubMed ID: 26226352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.
    Schalka S; Nunes S; Gomes Neto A
    An Bras Dermatol; 2012; 87(1):19-25. PubMed ID: 22481647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of superficial white onychomycosis with topical terbinafine cream.
    Goodfield MJ; Evans EG
    Br J Dermatol; 1999 Sep; 141(3):604-5. PubMed ID: 10583101
    [No Abstract]   [Full Text] [Related]  

  • 38. Nondermatophytic onychomycosis by Fusarium oxysporum in an immunocompetent host.
    Shah SR; Dalal BD; Modak MS
    J Mycol Med; 2016 Mar; 26(1):e18-21. PubMed ID: 26852190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study.
    Brenner MA; Harkless LB; Mendicino RW; Page JC
    J Am Podiatr Med Assoc; 2007; 97(3):195-202. PubMed ID: 17507527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report.
    Galitz J
    Cutis; 2001 Aug; 68(2 Suppl):23-4. PubMed ID: 11665725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.